ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AMLX Amylyx Pharmaceuticals Inc

2.00
0.00 (0.00%)
Pre Mercado
Última actualización: 03:08:03
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Amylyx Pharmaceuticals Inc AMLX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.00 03:08:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202408:00BWAmylyx Pharmaceuticals to Report First Quarter 2024..
10/4/202408:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/4/202404:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/4/202408:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/4/202404:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/4/202406:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/4/202404:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/3/202404:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/3/202404:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/3/202407:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/3/202404:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/3/202404:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
14/3/202408:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/3/202404:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/3/202407:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/3/202404:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/3/202406:10EDGAR2Form 8-K - Current report
08/3/202406:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
07/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202404:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
28/2/202417:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202404:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
23/2/202415:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
22/2/202415:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202407:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:08EDGAR2Form 8-K - Current report
22/2/202406:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202404:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
15/2/202415:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
15/2/202408:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/2/202404:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
08/2/202408:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
11/1/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202308:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
19/12/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202306:00EDGAR2Form 8-K - Current report
04/12/202308:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
29/11/202316:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202306:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
27/11/202308:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
21/11/202308:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
20/11/202319:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

Delayed Upgrade Clock